VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $262,333 | -2.0% | 11,748 | +11.8% | 0.00% | – |
Q2 2023 | $267,588 | -87.1% | 10,506 | -88.7% | 0.00% | – |
Q1 2023 | $2,082,018 | +89.1% | 93,364 | +101.3% | 0.00% | – |
Q4 2022 | $1,100,787 | +42.0% | 46,388 | -0.6% | 0.00% | – |
Q3 2022 | $775,000 | +4.0% | 46,679 | +24.7% | 0.00% | – |
Q2 2022 | $745,000 | +3.5% | 37,447 | +43.3% | 0.00% | – |
Q1 2022 | $720,000 | -76.7% | 26,126 | -65.1% | 0.00% | – |
Q4 2021 | $3,088,000 | -62.3% | 74,932 | -57.5% | 0.00% | -100.0% |
Q3 2021 | $8,191,000 | -48.0% | 176,348 | -55.2% | 0.00% | 0.0% |
Q2 2021 | $15,747,000 | -25.3% | 393,868 | +0.4% | 0.00% | -50.0% |
Q1 2021 | $21,083,000 | -41.6% | 392,222 | -46.8% | 0.00% | -33.3% |
Q4 2020 | $36,074,000 | +64.6% | 737,108 | +9.3% | 0.00% | +50.0% |
Q3 2020 | $21,911,000 | +14410.6% | 674,374 | +11439.6% | 0.00% | – |
Q2 2020 | $151,000 | +19.8% | 5,844 | +13.0% | 0.00% | – |
Q1 2020 | $126,000 | +53.7% | 5,172 | +77.5% | 0.00% | – |
Q4 2019 | $82,000 | – | 2,913 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |